Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Genome-wide CRISPR screens identify CD48 defining susceptibility to NK cytotoxicity in peripheral T-cell lymphomas

Masahiro Chiba, Joji Shimono, Takashi Ishio, Norio Takei, Kohei Kasahara, Reiki Ogasawara, Takahide Ara, Hideki Goto, Koh Izumiyama, Satoko Otsuguro, Liyanage P. Perera, Hiroo Hasegawa, Michiyuki Maeda, Satoshi Hashino, Katsumi Maenaka, Takanori Teshima, Thomas A. Waldmann, Yibin Yang, Masao Nakagawa

Blood (2022) 140 (18): 1951–1963.

https://doi.org/10.1182/blood.2022015646

Published: 2022

Includes: Supplemental data

Journal Articles

Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma

Blood (2022) 139 (10): 1541–1556.

https://doi.org/10.1182/blood.2021012734

Published: 2022

Includes: Supplemental data

Journal Articles

Genome-Wide CRISPR Library Screening Identifies CDK6 As Genetic Vulnerability in Adult T-Cell Leukemia/Lymphoma

Takashi Ishio, Joji Shimono, Sarvesh Kumar, Yuquan Lin, Emmanuel Bachy, Michael N. Petrus, Yandan Yang, Michiyuki Maeda, Hideki Goto, Satoshi Hashino, Takanori Teshima, MD, Thomas A. Waldmann, MD, Louis Staudt, MD, Masao Nakagawa

Blood (2019) 134 (Supplement_1): 3781.

https://doi.org/10.1182/blood-2019-124670

Published: 2019

Journal Articles

Risk Factor Analysis Of Non-Hodgkin Lymphoma-Associated Hemophagocytic Syndromes: A Multicenter Study

Hirozumi Sano, M.D., Ryoji Kobayashi, MD., PhD, Junji Tanaka, MD, PhD, Satoshi Hashino, MD, PhD, Shuichi Ota, MD, PhD, Yoshihiro Torimoto, MD, PhD, Yasutaka Kakinoki, MD, PhD, Satoshi Yamamoto, MD, PhD, Mitsutoshi Kurosawa, MD, PhD, Naoki Hatakeyama, MD, Yoshihito Haseyama, Hajime Sakai, Kazuya Sato, MD, PhD, Takashi Fukuhara, MD., PhD

Blood (2013) 122 (21): 1778.

https://doi.org/10.1182/blood.V122.21.1778.1778

Published: 2013

Journal Articles

Lymphopenia and an Elevated Monocyte Count At Diagnosis Do Not Predict a Poor Outcome After Autologous Transplants for Diffuse Large B-Cell Lymphoma in the First Remission

Mitsufumi Nishio, MD, PhD, Satoshi Yamamoto, MD, PhD, Tomoyuki Endo, MD, PhD, Katsuya Fujimoto, MD, PhD, Toshiya Sakai, MD, PhD, Takeshi Kondo, MD, PhD, Akio Shigematsu, MD, PhD, Junichi Sugita, MD, PhD, Satoshi Hashino, MD, PhD, Junji Tanaka, M.D., Masahiro Imamura, MD, PhD, Takanori Teshima, MD, PhD

Blood (2012) 120 (21): 4544.

https://doi.org/10.1182/blood.V120.21.4544.4544

Published: 2012

Journal Articles

Role of Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia in an HTLV-1 Non-Endemic Area of Japan.

Akio Shigematsu, MD, PhD, Junji Tanaka, MD, PhD, Naoki Kobayashi, MD, PhD, Hiroshi Yasui, MD, PhD, Motohiro Shindo, MD, PhD, Yasutaka Kakinoki, MD, PhD, Kakinoki Yasutaka, MD, PhD, Satoshi Iyama, MD, PhD, Kuroda HIroyuki, MD, PhD, Tsutsumi Yutaka, MD.PhD, Satoshi Hashino, MD, PhD, Masahiro Imamura, MD, PhD, Takanori Teshima, MD, PhD

Blood (2012) 120 (21): 3089.

https://doi.org/10.1182/blood.V120.21.3089.3089

Published: 2012

Journal Articles

Evaluation of Romiplostim In a Randomized Placebo-Controlled Phase 3 Study of a Japanese Population with Chronic Immune Thrombocytopenia (ITP).

Koji Miyazaki, MD, Yukari Shirasugi, MD, Kiyoshi Ando, MD, PhD, Yoshiaki Tomiyama, MD, Shinichiro Okamoto, MD, PhD, Mineo Kurokawa, MD, Keita Kirito, MD, Yuji Yonemura, MD, PhD, Shinichiro Mori, MD, Kensuke Usuki, MD, PhD, Koji Iwato, MD, PhD, Satoshi Hashino, MD, PhD, Helen Wei, PhD, Richard Lizambri, MD

Blood (2010) 116 (21): 3704.

https://doi.org/10.1182/blood.V116.21.3704.3704

Published: 2010

Journal Articles

Incidence and Risk of Post-Herpetic Neuralgia after Varicella Zoster Virus (VZV) Infection in Hematopoietic Cell Trasnplantation (HCT) Recipients.

Masahiro Onozawa, Satoshi Hashino, Takashi Fukuhara

Blood (2008) 112 (11): 1152.

https://doi.org/10.1182/blood.V112.11.1152.1152

Published: 2008

Journal Articles

DOCK180, a New Surrogate Marker to Distinguish CD34 Positive Acute Leukemia Cells from CD34 Positive Normal Hematopoietic Stem/Progenitor Cells.

Mitsufumi Nishio, MD, PhD, Kohki Kumano, M.D., Ph.D., Katsuya Fujimoto, M.D., Ph.D., Tomoyuki Endo, M.D., Ph.D., Satoshi Yamamoto, M.D., Ph.D., Akio Shigematsu, MD, PhD, Takeshi Kondo, MD., PhD, Junji Tanaka, MD, PhD, Satoshi Hashino, Masahiro Imamura, Hiroshi Nishihara, M.D., Ph.D., Norihiro Sato, M.D., Ph.D., Takao Koike, M.D., Ph.D.

Blood (2008) 112 (11): 1476.

https://doi.org/10.1182/blood.V112.11.1476.1476

Published: 2008

Journal Articles

A Phase 2 Open-Label, Sequential-Cohort, Dose-Escalation Study of AMG 531 in Japanese Patients with Chronic Immune Thrombocytopenic Purpura (ITP).

Yukari Shirasugi, Kiyoshi Ando, Satoshi Hashino, Toshiro Nagasawa, Yoshiyuki Kurata, Yuji Kishimoto, Koji Iwato, Yusuke Sonehara, Masayuki Ohkura, Tomoko Ohtsu, Janet L. Nichol

Blood (2007) 110 (11): 1308.

https://doi.org/10.1182/blood.V110.11.1308.1308

Published: 2007

Journal Articles

A Chimeric Gene, FIP1L1-RARα, Is Isolated from t(4;17)-Positive Acute Promyelocytic Leukemia; a Report of Cloning and Functional Analysis.

Takeshi Kondo, MD, PhD, Akio Mori, MD, PhD, Masahiro Onozawa, MD, PhD, Kaoru Kahata, MD, PhD, Satoshi Hashino, MD, PhD, Junji Tanaka, MD, PhD, Masahiro Imamura, MD, PhD, Masanobu Morioka, MD, PhD, Masahiro Asaka, MD, PhD

Blood (2007) 110 (11): 1820.

https://doi.org/10.1182/blood.V110.11.1820.1820

Published: 2007

Journal Articles

Donor-Type Myelodysplastic Syndrome with t(2;3) and Monosomy 7 after Allogeneic Peripheral Blood Stem Cell Transplantation and Liver Transplantation in a Patient with Severe-Type Aplastic Anemia.

Satoshi Hashino, MD, PhD, Fumie Fujisawa, MD, Takeshi Kondo, MD, PhD, Masahiro Imamura, MD, PhD, Kazuya Sato, MD, PhD, Yoshihiro Torimoto, MD, PhD, Yutaka Kohgo, MD, PhD, Keisuke Kimura, MD, PhD, Hiroyuki Furukawa, MD, PhD, Satoru Todo, MD, PhD, Masahiro Asaka, MD, PhD

Blood (2006) 108 (11): 5357.

https://doi.org/10.1182/blood.V108.11.5357.5357

Published: 2006

Journal Articles

HBV Reverse Seroconversion and Intervention with Vaccination after Allogeneic HSCT in Patients with Previous HBV Infection.

Masahiro Onozawa, MD, Hiroe Kanamori, MD, Kaoru Kahata, MD, Takeshi Kondo, MD,PhD, Shuichi Ota, MD,PhD, Satoshi Hashino, MD,PhD, Junji Tanaka, MD,PhD, Masahiro Imamura, MD,PhD, Masahiro Asaka, MD,PhD

Blood (2006) 108 (11): 2921.

https://doi.org/10.1182/blood.V108.11.2921.2921

Published: 2006

Journal Articles

Chimeric Leukemic Protein PLZF/RARα Functions as an Adoptor for Cul3-Based E3 Ubiquitin Ligase To Regulate Proteosomal Degradation of RXRα.

Masahiro Onozawa, MD, Takeshi Kondo, MD, PhD, Hiroe Kanamori, MD, Kaoru Kahata, MD, PhD, Satoshi Hashino, MD, PhD, Masahiro Asaka, MD, PhD

Blood (2006) 108 (11): 1926.

https://doi.org/10.1182/blood.V108.11.1926.1926

Published: 2006

Journal Articles

Clinical Efficacy and Cost Benefit of Low-Dose Granulocyte Colony-Stimulating Factor after Standard Chemotherapy in Patients with Non-Hodgkin’s Lymphoma.

Satoshi Hashino, MD, PhD, Masanobu Morioka, MD, PhD, Tatsuro Irie, MD, PhD, Noriyuki Shiroshita, MD, PhD, Tsugumichi Kawamura, MD, PhD, Sachiko Suzuki, MD, PhD, Hiroshi Iwasaki, MD, PhD, Shintaro Umehara, MD, PhD, Yasutaka Kakinoki, MD, PhD, Mitsutoshi Kurosawa, MD, PhD, Kaoru Kahata, MD, PhD, Koh Izumiyama, MD, PhD, Hajime Kobayashi, MD, Masahiro Onozawa, MD, Mutsumi Takahata, MD, Fumie Fujisawa, MD, Takeshi Kondo, MD, PhD, Masahiro Asaka, MD, PhD

Blood (2006) 108 (11): 4671.

https://doi.org/10.1182/blood.V108.11.4671.4671

Published: 2006

Journal Articles

CD56 Expression Is the Potent Prognostic Marker of the Thalidomide Efficacy in the Patients with Multiple Myeloma.

Akio Mori, MD, PhD, Yutaka Tsutsumi, MD, PhD, Satoshi Hashino, MD, PhD, Hiroe Kanamori, MD, Makoto Ibata, MD, Shinobu Mashiko, MD, Nobuo Masauzi, MD, PhD, Masahiro Asaka, MD, PhD, Masahiro Imamura, MD, PhD

Blood (2005) 106 (11): 5142.

https://doi.org/10.1182/blood.V106.11.5142.5142

Published: 2005

Journal Articles

Transition of Humoral Immunity and Clinical VZV Reactivation in Hematopoietic Stem Cell Transplantation Recipients.

Masahiro Onozawa, MD, Satoshi Hashino, MD, PhD, Takeshi Kondo, MD, PhD, Shuichi Ota, MD, Junji Tanaka, MD, PhD, Masahiro Imamura, MD, PhD, Masahiro Asaka, MD, PhD

Blood (2005) 106 (11): 5352.

https://doi.org/10.1182/blood.V106.11.5352.5352

Published: 2005

Journal Articles

Evaluation of MRD after Administration of Imatinib by Measurement of Real-Time Quantitative PCR-Based Major bcr/abl mRNA.

Mutsumi Takahata, MD, Satoshi Hashino, MD, Fumie Fujisawa, MD, Takeshi Kondo, MD, Syuichi Ota, MD, Sumiko Kobayashi, MD, Junji Tanaka, MD, Masahiro Imamura, MD, Masahiro Asaka, MD

Blood (2004) 104 (11): 4407.

https://doi.org/10.1182/blood.V104.11.4407.4407

Published: 2004

Journal Articles

A Clinical Trial of VVR Rate in Preoperative Autologous Blood Donation by Adults and Pediatrics Patients with or without IV Fluid Infusion.

Sumiko Kobayashi, M.D., Ph. D, Norihiro Sato, M.D., Ph.D, Satoshi Hashino, M.D., Ph.D, Takeshi Kondo, M.D., Ph.D, Takao Koike, M.D., Ph.D

Blood (2004) 104 (11): 4112.

https://doi.org/10.1182/blood.V104.11.4112.4112

Published: 2004

Journal Articles

Effect of Granulocytes Colony Stimulating Factor on Decreased IL-12 p40 Production by Chemotherapy.

Tomomi Toubai, Junji Tanaka, Shuichi Ota, Takashi Fukuhara, Satoshi Hashino, Takeshi Kondo, Masanobu Morioka, Tsugumichi Kawamura, Nobuo Masauzi, Yasutaka Kakinoki, Hajime Kobayashi, Yasuyuki Kunieda, Masaharu Kasai, Mitsutoshi Kurosawa, Masahiro Imamura

Blood (2004) 104 (11): 4550.

https://doi.org/10.1182/blood.V104.11.4550.4550

Published: 2004

NARROW

Genome-wide CRISPR screens identify CD48 defining susceptibility to NK cytotoxicity in peripheral T-cell lymphomas

Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma

Genome-Wide CRISPR Library Screening Identifies CDK6 As Genetic Vulnerability in Adult T-Cell Leukemia/Lymphoma

Risk Factor Analysis Of Non-Hodgkin Lymphoma-Associated Hemophagocytic Syndromes: A Multicenter Study

Lymphopenia and an Elevated Monocyte Count At Diagnosis Do Not Predict a Poor Outcome After Autologous Transplants for Diffuse Large B-Cell Lymphoma in the First Remission

Role of Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia in an HTLV-1 Non-Endemic Area of Japan.

Evaluation of Romiplostim In a Randomized Placebo-Controlled Phase 3 Study of a Japanese Population with Chronic Immune Thrombocytopenia (ITP).

Incidence and Risk of Post-Herpetic Neuralgia after Varicella Zoster Virus (VZV) Infection in Hematopoietic Cell Trasnplantation (HCT) Recipients.

DOCK180, a New Surrogate Marker to Distinguish CD34 Positive Acute Leukemia Cells from CD34 Positive Normal Hematopoietic Stem/Progenitor Cells.

A Phase 2 Open-Label, Sequential-Cohort, Dose-Escalation Study of AMG 531 in Japanese Patients with Chronic Immune Thrombocytopenic Purpura (ITP).

A Chimeric Gene, FIP1L1-RARα, Is Isolated from t(4;17)-Positive Acute Promyelocytic Leukemia; a Report of Cloning and Functional Analysis.

Donor-Type Myelodysplastic Syndrome with t(2;3) and Monosomy 7 after Allogeneic Peripheral Blood Stem Cell Transplantation and Liver Transplantation in a Patient with Severe-Type Aplastic Anemia.

HBV Reverse Seroconversion and Intervention with Vaccination after Allogeneic HSCT in Patients with Previous HBV Infection.

Chimeric Leukemic Protein PLZF/RARα Functions as an Adoptor for Cul3-Based E3 Ubiquitin Ligase To Regulate Proteosomal Degradation of RXRα.

Clinical Efficacy and Cost Benefit of Low-Dose Granulocyte Colony-Stimulating Factor after Standard Chemotherapy in Patients with Non-Hodgkin’s Lymphoma.

CD56 Expression Is the Potent Prognostic Marker of the Thalidomide Efficacy in the Patients with Multiple Myeloma.

Transition of Humoral Immunity and Clinical VZV Reactivation in Hematopoietic Stem Cell Transplantation Recipients.

Evaluation of MRD after Administration of Imatinib by Measurement of Real-Time Quantitative PCR-Based Major bcr/abl mRNA.

A Clinical Trial of VVR Rate in Preoperative Autologous Blood Donation by Adults and Pediatrics Patients with or without IV Fluid Infusion.

Effect of Granulocytes Colony Stimulating Factor on Decreased IL-12 p40 Production by Chemotherapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only